Key result
Percutaneous ultrasound-guided core biopsy yields diagnostic samples in ~92% of cardiac tumors without complications.
Why the study?
The clinical value, safety, and role of ultrasound-guided percutaneous core needle biopsy in diagnosing cardiac tumors and guiding treatment strategies for intermural and pericardial tumors needed investigation.
Does percutaneous ultrasound-guided core needle biopsy provide a safe and effective alternative to surgical biopsy for diagnosing intermural and pericardial cardiac tumors?
Observational (n=18)
No
Does percutaneous ultrasound-guided core needle biopsy provide a safe and effective alternative to surgical biopsy for diagnosing intermural and pericardial cardiac tumors?
Percutaneous ultrasound-guided core needle biopsy is a safe and effective minimally invasive method for diagnosing cardiac intermural and pericardial tumors, potentially avoiding unnecessary open-heart surgery.
May support percutaneous biopsy as a diagnostic option for select cardiac tumors; leaves open need for larger prospective validation before practice change.
Objective: The aims of this study are to investigate the clinical value and practical safety of ultrasound-guided percutaneous core needle biopsy on diagnosing cardiac tumor and to discuss the treatment strategy for cardiac intermural and pericardial tumors. Methods: The clinical data were retrospectively collected for patients with intermural and pericardial cardiac tumors. The patients were divided into groups of surgical resection, surgical resection after obtaining pathological tissue by PUS-CNB, and/or radiotherapy according to the treatment modality. Ultrasound-guided aspiration biopsy was divided into cardiac tumor biopsy and extracardiac lesion biopsy according to patient conditions. The surgical time was recorded, and the safety and clinical application value of PUS-CNB for the diagnosis of cardiac tumors were evaluated in terms of complications and satisfaction with pathological sampling. Results: A total of 18 patient cases were collected, and PUS-CNB of cardiac tumors was performed in 8 cases, with sampling times averaging 15.6 ± 3.0 min. Four cases of cardiac tumors combined with extracardiac tumors were biopsied, with puncture times averaging 13.0 ± 2.9 min. All 12 biopsied patients had no postoperative complications. Except for 1 failed biopsy, the biopsies were successful and the pathological results were consistent with the clinical diagnosis with a satisfaction rate of 91.7%. Except for two cases of surgical resection, the rest were considered for conservative treatment. Surgical resection and/or biopsy were performed in six cases, and two cases were aggravated after surgery. The final pathology of all 17 cardiac tumors was malignant. Conclusion: PUS-CNB is safe and effective, providing a simple and undemanding method for accurate diagnosis of cardiac intermural and pericardial tumors while avoiding unnecessary open-heart surgery.
No takes yet. Share an insight, caveat, or question.
Xie et al. (2022) conducted an observational in Intermural and pericardial cardiac tumors (n=18). Percutaneous ultrasound-guided core needle biopsy (PUS-CNB) vs. Surgical resection or biopsy was evaluated on Satisfaction with pathological sampling (success rate). Percutaneous ultrasound-guided core needle biopsy successfully obtained diagnostic pathological samples in 91.7% of patients with cardiac tumors, with no postoperative complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: